|
G |
Acox1 |
acyl-Coenzyme A oxidase 1, palmitoyl |
multiple interactions increases activity |
ISO |
Chromium inhibits the reaction [Alloxan results in increased activity of ACOX1 protein]; chromium tripicolinate inhibits the reaction [Alloxan results in increased activity of ACOX1 protein] |
CTD |
PMID:19693677 |
|
NCBI chr11:116,062,714...116,089,605
Ensembl chr11:116,062,714...116,089,871
|
|
G |
Actb |
actin, beta |
decreases expression |
EXP |
Alloxan results in decreased expression of ACTB mRNA |
CTD |
PMID:12137914 |
|
NCBI chr 5:142,888,870...142,892,509
Ensembl chr 5:142,888,870...142,892,509
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
ISO |
[Alloxan co-treated with Niacinamide] affects the expression of ADIPOQ protein |
CTD |
PMID:26429928 |
|
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
decreases phosphorylation multiple interactions |
EXP ISO |
Alloxan results in decreased phosphorylation of AKT1 protein Phycocyanin inhibits the reaction [Alloxan results in decreased phosphorylation of AKT1 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased phosphorylation of AKT1 protein]]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:26827782 PMID:33359794 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
decreases expression multiple interactions increases expression |
ISO |
Alloxan results in decreased expression of APAF1 protein Taurine inhibits the reaction [Alloxan results in increased expression of APAF1 protein] |
CTD |
PMID:21982801 PMID:23092809 |
|
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
|
|
G |
Atp2a1 |
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
multiple interactions decreases expression |
ISO |
imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of ATP2A1 protein] |
CTD |
PMID:28483572 |
|
NCBI chr 7:126,045,032...126,062,245
Ensembl chr 7:126,045,030...126,062,280
|
|
G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
decreases expression |
ISO |
Alloxan results in decreased expression of ATP2A2 protein |
CTD |
PMID:28483572 |
|
NCBI chr 5:122,591,576...122,640,288
Ensembl chr 5:122,591,576...122,640,288
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression multiple interactions |
ISO |
Alloxan results in increased expression of BAD protein Taurine inhibits the reaction [Alloxan results in increased expression of BAD protein] |
CTD |
PMID:22138235 |
|
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions increases expression |
ISO |
Taurine inhibits the reaction [Alloxan results in increased expression of BAX protein] |
CTD |
PMID:21982801 PMID:22138235 PMID:23092809 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
decreases expression multiple interactions |
ISO |
Alloxan results in decreased expression of BCL2 protein Taurine inhibits the reaction [Alloxan results in decreased expression of BCL2 protein] |
CTD |
PMID:21982801 PMID:22138235 PMID:23092809 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
decreases expression multiple interactions |
ISO |
Alloxan results in decreased expression of BCL2L1 protein Taurine inhibits the reaction [Alloxan results in decreased expression of BCL2L1 protein] |
CTD |
PMID:22138235 |
|
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases expression |
ISO |
D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in increased activity of CASP3 protein]; Taurine inhibits the reaction [Alloxan results in increased expression of CASP3 protein modified form] |
CTD |
PMID:21982801 PMID:22138235 PMID:23092809 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp9 |
caspase 9 |
increases activity increases expression multiple interactions |
ISO |
Alloxan results in increased activity of CASP9 protein Alloxan results in increased expression of CASP9 protein; Alloxan results in increased expression of CASP9 protein modified form D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in increased activity of CASP9 protein]; Taurine inhibits the reaction [Alloxan results in increased expression of CASP9 protein modified form]; Taurine inhibits the reaction [Alloxan results in increased expression of CASP9 protein] |
CTD |
PMID:21982801 PMID:22138235 PMID:23092809 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cat |
catalase |
multiple interactions decreases expression decreases activity |
ISO EXP |
3,4-dihydroxyphenylethanol inhibits the reaction [Alloxan results in decreased expression of CAT protein]; Chromium inhibits the reaction [Alloxan results in decreased activity of CAT protein]; chromium tripicolinate inhibits the reaction [Alloxan results in decreased activity of CAT protein]; D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in decreased activity of CAT protein]; Plant Extracts inhibits the reaction [Alloxan results in decreased expression of CAT protein] Plant Oils inhibits the reaction [Alloxan results in decreased activity of CAT protein]; Quercetin inhibits the reaction [Alloxan results in decreased activity of CAT protein] |
CTD |
PMID:10871429 PMID:19393637 PMID:19693677 PMID:21982801 PMID:24946265 PMID:28419827 More...
|
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [Cathelicidins results in increased expression of CCL2 protein]] |
CTD |
PMID:18949387 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4I1 |
multiple interactions decreases expression |
ISO |
imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of COX4I1 protein] |
CTD |
PMID:28483572 |
|
NCBI chr 8:121,394,964...121,400,948
Ensembl chr 8:121,394,961...121,400,946
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions affects localization |
ISO |
Taurine inhibits the reaction [Alloxan affects the localization of CYCS protein] |
CTD |
PMID:22138235 PMID:23092809 |
|
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
EXP |
Alloxan results in increased expression of DDIT3 mRNA; Alloxan results in increased expression of DDIT3 protein |
CTD |
PMID:30076216 |
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Foxp3 |
forkhead box P3 |
multiple interactions decreases expression |
EXP |
platycodin D inhibits the reaction [Alloxan results in decreased expression of FOXP3 protein] |
CTD |
PMID:25887267 |
|
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
increases activity multiple interactions |
ISO |
Alloxan results in increased activity of G6PC1 protein Sodium Selenite inhibits the reaction [Alloxan results in increased activity of G6PC1 protein] |
CTD |
PMID:25779343 |
|
NCBI chr11:101,258,542...101,268,729
Ensembl chr11:101,258,387...101,268,729
|
|
G |
Gck |
glucokinase |
multiple interactions decreases expression |
EXP ISO |
Glucose inhibits the reaction [Alloxan results in decreased expression of GCK mRNA]; Phycocyanin inhibits the reaction [Alloxan results in decreased expression of GCK protein] Alloxan results in decreased expression of GCK mRNA; Alloxan results in decreased expression of GCK protein ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCK mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCK protein] |
CTD |
PMID:12137914 PMID:26827782 PMID:33359794 |
|
NCBI chr11:5,850,816...5,900,081
Ensembl chr11:5,850,820...5,900,081
|
|
G |
Gckr |
glucokinase regulatory protein |
decreases expression multiple interactions |
EXP |
Alloxan results in decreased expression of GCKR protein Phycocyanin inhibits the reaction [Alloxan results in decreased expression of GCKR protein] |
CTD |
PMID:26827782 |
|
NCBI chr 5:31,454,594...31,484,646
Ensembl chr 5:31,454,787...31,484,658
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions decreases expression |
ISO |
ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCLC mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCLC protein]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCLC protein]] Alloxan results in decreased expression of GCLC mRNA; Alloxan results in decreased expression of GCLC protein |
CTD |
PMID:33359794 |
|
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions |
ISO |
[Alloxan results in increased susceptibility to titanium dioxide] which results in increased activity of GPT protein |
CTD |
PMID:23873220 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Gsr |
glutathione reductase |
multiple interactions decreases activity |
ISO |
D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in decreased activity of GSR protein] |
CTD |
PMID:21982801 |
|
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions decreases expression |
ISO |
ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of HMOX1 mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of HMOX1 protein]] Alloxan results in decreased expression of HMOX1 mRNA; Alloxan results in decreased expression of HMOX1 protein |
CTD |
PMID:33359794 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hspa5 |
heat shock protein 5 |
increases expression |
EXP |
Alloxan results in increased expression of HSPA5 mRNA |
CTD |
PMID:30076216 |
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [Cathelicidins results in increased expression of ICAM1 protein]] |
CTD |
PMID:18949387 |
|
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
EXP |
Alloxan results in decreased expression of and results in decreased secretion of IL10 protein; platycodin D inhibits the reaction [Alloxan results in decreased expression of and results in decreased secretion of IL10 protein] |
CTD |
PMID:25887267 |
|
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il12b |
interleukin 12b |
decreases expression |
EXP |
Alloxan results in decreased expression of IL12B protein |
CTD |
PMID:16249388 |
|
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
EXP |
Alloxan results in increased expression of and results in increased secretion of IL17A protein; platycodin D inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL17A protein] |
CTD |
PMID:25887267 |
|
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
Alloxan results in increased expression of and results in increased secretion of IL1B protein; platycodin D inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL1B protein]; Rosiglitazone inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL1B protein] |
CTD |
PMID:25887267 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO EXP |
Taurine inhibits the reaction [Alloxan results in increased expression of IL6 protein] Alloxan results in increased expression of and results in increased secretion of IL6 protein; platycodin D inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL6 protein]; Rosiglitazone inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL6 protein] |
CTD |
PMID:22138235 PMID:25887267 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Ins1 |
insulin I |
multiple interactions decreases expression decreases secretion |
EXP ISO |
Plant Oils inhibits the reaction [Alloxan results in decreased expression of INS1 protein] Alloxan results in decreased secretion of INS1 protein [Alloxan co-treated with Homocysteine] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [Sertraline binds to 2-Hydroxypropyl-beta-cyclodextrin] inhibits the reaction [Alloxan results in decreased expression of INS1 protein]; Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]; D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in decreased expression of INS1 protein]; ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; Plant Preparations inhibits the reaction [Alloxan results in decreased secretion of INS1 protein]; Sertraline inhibits the reaction [Alloxan results in decreased expression of INS1 protein] |
CTD |
PMID:19393637 PMID:21050842 PMID:21982801 PMID:26593071 PMID:27317948 PMID:28419827 PMID:33359794 More...
|
|
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
|
|
G |
Insr |
insulin receptor |
decreases phosphorylation multiple interactions |
ISO |
Alloxan results in decreased phosphorylation of INSR protein Taurine inhibits the reaction [Alloxan results in decreased phosphorylation of INSR protein] |
CTD |
PMID:22138235 |
|
NCBI chr 8:3,200,922...3,329,649
Ensembl chr 8:3,172,061...3,329,617
|
|
G |
Irs1 |
insulin receptor substrate 1 |
decreases phosphorylation multiple interactions affects phosphorylation |
ISO EXP |
Alloxan results in decreased phosphorylation of IRS1 protein Taurine inhibits the reaction [Alloxan results in decreased phosphorylation of IRS1 protein] Alloxan affects the phosphorylation of IRS1 protein Phycocyanin inhibits the reaction [Alloxan affects the phosphorylation of IRS1 protein] |
CTD |
PMID:22138235 PMID:26827782 |
|
NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO |
Alloxan results in increased phosphorylation of MAPK1 protein ginsenoside Rh4 inhibits the reaction [Alloxan results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:33359794 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
increases phosphorylation multiple interactions |
ISO |
Alloxan results in increased phosphorylation of MAPK3 protein ginsenoside Rh4 inhibits the reaction [Alloxan results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:33359794 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mfn2 |
mitofusin 2 |
multiple interactions decreases expression |
ISO |
imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of MFN2 protein] |
CTD |
PMID:28483572 |
|
NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
|
|
G |
Mpo |
myeloperoxidase |
increases activity multiple interactions |
ISO |
Alloxan results in increased activity of MPO protein Taurine inhibits the reaction [Alloxan results in increased activity of MPO protein] |
CTD |
PMID:22138235 |
|
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
|
|
G |
Ndufa9 |
NADH:ubiquinone oxidoreductase subunit A9 |
decreases expression multiple interactions |
ISO |
Alloxan results in decreased expression of NDUFA9 protein imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of NDUFA9 protein] |
CTD |
PMID:28483572 |
|
NCBI chr 6:126,798,826...126,826,107
Ensembl chr 6:126,798,684...126,826,099
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
affects localization multiple interactions decreases expression |
ISO |
Alloxan affects the localization of NFE2L2 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan affects the localization of NFE2L2 protein]]; ginsenoside Rh4 inhibits the reaction [Alloxan affects the localization of NFE2L2 protein]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NFE2L2 mRNA]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCLC protein]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of HMOX1 protein]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NQO1 protein]] |
CTD |
PMID:33359794 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nos1 |
nitric oxide synthase 1, neuronal |
decreases expression |
EXP |
Alloxan results in decreased expression of NOS1 mRNA |
CTD |
PMID:30076216 |
|
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
increases expression |
EXP |
Alloxan results in increased expression of NOS2 mRNA |
CTD |
PMID:30076216 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
decreases expression multiple interactions |
ISO |
Alloxan results in decreased expression of NQO1 mRNA; Alloxan results in decreased expression of NQO1 protein ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NQO1 mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NQO1 protein]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NQO1 protein]] |
CTD |
PMID:33359794 |
|
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
multiple interactions |
ISO |
Alloxan affects the reaction [imisopasem manganese results in increased expression of NRF1 protein] |
CTD |
PMID:28483572 |
|
NCBI chr 6:30,047,984...30,153,462
Ensembl chr 6:30,047,987...30,153,457
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
increases degradation multiple interactions |
ISO |
Alloxan results in increased degradation of PARP1 protein D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in increased degradation of PARP1 protein] |
CTD |
PMID:21982801 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
decreases expression multiple interactions |
ISO |
Alloxan results in decreased expression of PDX1 mRNA; Alloxan results in decreased expression of PDX1 protein ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of PDX1 mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of PDX1 protein] |
CTD |
PMID:33359794 |
|
NCBI chr 5:147,206,907...147,212,658
Ensembl chr 5:147,206,769...147,212,658
|
|
G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
decreases expression multiple interactions |
ISO |
Alloxan results in decreased expression of PPARGC1A protein imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of PPARGC1A protein] |
CTD |
PMID:28483572 |
|
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions increases expression |
ISO |
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [TNF results in increased phosphorylation of RELA protein]] Alloxan results in increased expression of RELA protein Taurine inhibits the reaction [Alloxan results in increased expression of RELA protein] |
CTD |
PMID:19020780 PMID:22138235 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Rorc |
RAR-related orphan receptor gamma |
increases expression multiple interactions |
EXP |
Alloxan results in increased expression of RORC protein platycodin D inhibits the reaction [Alloxan results in increased expression of RORC protein] |
CTD |
PMID:25887267 |
|
NCBI chr 3:94,280,106...94,305,583
Ensembl chr 3:94,280,101...94,305,583
|
|
G |
Sdha |
succinate dehydrogenase complex, subunit A, flavoprotein (Fp) |
decreases expression multiple interactions |
ISO |
Alloxan results in decreased expression of SDHA protein imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of SDHA protein] |
CTD |
PMID:28483572 |
|
NCBI chr13:74,470,374...74,498,359
Ensembl chr13:74,470,373...74,498,399
|
|
G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
decreases expression multiple interactions |
EXP ISO |
Alloxan results in decreased expression of SLC2A2 mRNA Glucose inhibits the reaction [Alloxan results in decreased expression of SLC2A2 mRNA] Alloxan results in decreased expression of SLC2A2 mRNA; Alloxan results in decreased expression of SLC2A2 protein ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of SLC2A2 mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of SLC2A2 protein] |
CTD |
PMID:12137914 PMID:33359794 |
|
NCBI chr 3:28,752,052...28,782,510
Ensembl chr 3:28,752,052...28,785,508
|
|
G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
affects localization multiple interactions decreases expression |
ISO EXP |
Alloxan affects the localization of SLC2A4 protein imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of SLC2A4 protein]; Taurine inhibits the reaction [Alloxan affects the localization of SLC2A4 protein] Quercetin inhibits the reaction [Alloxan results in decreased expression of SLC2A4 protein] |
CTD |
PMID:22138235 PMID:24946265 PMID:28483572 |
|
NCBI chr11:69,833,112...69,839,040
Ensembl chr11:69,833,365...69,839,014
|
|
G |
Sod1 |
superoxide dismutase 1, soluble |
affects response to substance multiple interactions decreases activity |
EXP ISO |
SOD1 protein affects the susceptibility to Alloxan Sulfur Dioxide inhibits the reaction [Alloxan results in decreased activity of SOD1 protein] |
CTD |
PMID:10871429 PMID:18502742 |
|
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [TNF results in increased phosphorylation of RELA protein]] Taurine inhibits the reaction [Alloxan results in increased expression of TNF protein] Alloxan results in increased expression of and results in increased secretion of TNF protein; platycodin D inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of TNF protein]; Rosiglitazone inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of TNF protein] |
CTD |
PMID:19020780 PMID:22138235 PMID:25887267 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
increases expression |
EXP |
Alloxan results in increased expression of TRPM7 mRNA; Alloxan results in increased expression of TRPM7 protein |
CTD |
PMID:30076216 |
|
NCBI chr 2:126,633,478...126,718,181
Ensembl chr 2:126,633,485...126,718,150
|
|
G |
Uqcrc2 |
ubiquinol cytochrome c reductase core protein 2 |
multiple interactions increases expression |
ISO |
imisopasem manganese promotes the reaction [Alloxan results in increased expression of UQCRC2 protein] |
CTD |
PMID:28483572 |
|
NCBI chr 7:120,234,412...120,258,746
Ensembl chr 7:120,234,399...120,258,747
|
|
G |
Xdh |
xanthine dehydrogenase |
increases activity multiple interactions |
ISO |
Alloxan results in increased activity of XDH protein Taurine inhibits the reaction [Alloxan results in increased activity of XDH protein] |
CTD |
PMID:22138235 |
|
NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
|
|